Abbratech Inc.
Branford, US · 1 known investors
AbbraTech develops a platform technology for the discovery, engineering, and validation of antibodies, targeting disease-relevant proteins that are difficult to address with conventional approaches. It works with industry and academic partners to develop antibody therapies for conditions such as cancer, immune disorders, and viral infections.
Founders & leadership
MP
Michael P. WeinerFounder & CEO
MW
Michael WeinerinFounder
Investors · 1
Competitors · 2
by search overlapAbcam4 shared keywordsSupplier of protein research tools to life scientists. Publicly listed on the LSE following an IPO.
Triple Ring Technologies3 shared keywords
Companies competing with Abbratech Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $296.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $295.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $339.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $253.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Abbratech Inc. do?
- AbbraTech develops a platform technology for the discovery, engineering, and validation of antibodies, targeting disease-relevant proteins that are difficult to address with conventional approaches. It works with industry and academic partners to develop antibody therapies for conditions such as cancer, immune disorders, and viral infections.
- Who founded Abbratech Inc.?
- Abbratech Inc. was founded by Michael P. Weiner, Michael Weiner.
- Who are Abbratech Inc.'s investors?
- Abbratech Inc.'s investors include Connecticut Innovations.
- Where is Abbratech Inc. headquartered?
- Abbratech Inc. is headquartered in Branford, US.